343 related articles for article (PubMed ID: 23290560)
1. Effects of intensive cognitive-behavioral therapy on cingulate neurochemistry in obsessive-compulsive disorder.
O'Neill J; Gorbis E; Feusner JD; Yip JC; Chang S; Maidment KM; Levitt JG; Salamon N; Ringman JM; Saxena S
J Psychiatr Res; 2013 Apr; 47(4):494-504. PubMed ID: 23290560
[TBL] [Abstract][Full Text] [Related]
2. MRSI correlates of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder.
O'Neill J; Piacentini JC; Chang S; Levitt JG; Rozenman M; Bergman L; Salamon N; Alger JR; McCracken JT
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jan; 36(1):161-8. PubMed ID: 21983143
[TBL] [Abstract][Full Text] [Related]
3. Glutamate in Pediatric Obsessive-Compulsive Disorder and Response to Cognitive-Behavioral Therapy: Randomized Clinical Trial.
O'Neill J; Piacentini J; Chang S; Ly R; Lai TM; Armstrong CC; Bergman L; Rozenman M; Peris T; Vreeland A; Mudgway R; Levitt JG; Salamon N; Posse S; Hellemann GS; Alger JR; McCracken JT; Nurmi EL
Neuropsychopharmacology; 2017 Nov; 42(12):2414-2422. PubMed ID: 28409563
[TBL] [Abstract][Full Text] [Related]
4. Brain neurochemistry in unmedicated obsessive-compulsive disorder patients and effects of 12-week escitalopram treatment:
Parmar A; Sharan P; Khandelwal SK; Agarwal K; Sharma U; Jagannathan NR
Psychiatry Clin Neurosci; 2019 Jul; 73(7):386-393. PubMed ID: 30973183
[TBL] [Abstract][Full Text] [Related]
5. Spectroscopic abnormalities in the pregenual anterior cingulate cortex in obsessive-compulsive disorder using proton magnetic resonance spectroscopy: a controlled study.
Kosová E; Pajuelo D; Fajnerová I; Greguš D; Brunovský M; Stopková P; Škoch A; Fürstová P; Španiel F; Horáček J
BMC Psychiatry; 2023 Oct; 23(1):734. PubMed ID: 37817131
[TBL] [Abstract][Full Text] [Related]
6. Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder.
Yücel M; Wood SJ; Wellard RM; Harrison BJ; Fornito A; Pujol J; Velakoulis D; Pantelis C
Aust N Z J Psychiatry; 2008 Jun; 42(6):467-77. PubMed ID: 18465373
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal changes in neurometabolite concentrations in the dorsal anterior cingulate cortex after concentrated exposure therapy for obsessive-compulsive disorder.
de Joode NT; Thorsen AL; Vester EL; Vriend C; Pouwels PJW; Hagen K; Ousdal OT; Hansen B; Kvale G; van den Heuvel OA
J Affect Disord; 2022 Feb; 299():344-352. PubMed ID: 34920037
[TBL] [Abstract][Full Text] [Related]
8. Direct changes of neurometabolic concentrations in the pregenual anterior cingulate cortex among obsessive-compulsive patients after repetitive transcranial magnetic stimulation treatment.
Luo G; Wang S; Yao S; Quan D; Guo G; Gao J; Zheng H
J Affect Disord; 2023 Jul; 333():79-85. PubMed ID: 37080494
[TBL] [Abstract][Full Text] [Related]
9. Cingulate and thalamic metabolites in obsessive-compulsive disorder.
O'Neill J; Lai TM; Sheen C; Salgari GC; Ly R; Armstrong C; Chang S; Levitt JG; Salamon N; Alger JR; Feusner JD
Psychiatry Res Neuroimaging; 2016 Aug; 254():34-40. PubMed ID: 27317876
[TBL] [Abstract][Full Text] [Related]
10. A 1H magnetic resonance spectroscopy study in adults with obsessive compulsive disorder: relationship between metabolite concentrations and symptom severity.
Starck G; Ljungberg M; Nilsson M; Jönsson L; Lundberg S; Ivarsson T; Ribbelin S; Ekholm S; Carlsson A; Forssell-Aronsson E; Carlsson ML
J Neural Transm (Vienna); 2008 Jul; 115(7):1051-62. PubMed ID: 18528631
[TBL] [Abstract][Full Text] [Related]
11. Regional metabolic heterogeneity in anterior cingulate cortex in major depressive disorder: A multi-voxel
He J; Wang D; Ban M; Kong L; Xiao Q; Yuan F; Zhu X
J Affect Disord; 2022 Dec; 318():263-271. PubMed ID: 36087788
[TBL] [Abstract][Full Text] [Related]
12. 1H-MRS of the anterior cingulate cortex in childhood and adolescent obsessive-compulsive disorder: a case-control study.
Ortiz AE; Ortiz AG; Falcon C; Morer A; Plana MT; Bargalló N; Lázaro L
Eur Neuropsychopharmacol; 2015 Jan; 25(1):60-8. PubMed ID: 25499604
[TBL] [Abstract][Full Text] [Related]
13. Abnormalities in metabolite concentrations in tourette's disorder and obsessive-compulsive disorder-A proton magnetic resonance spectroscopy study.
Fan S; Cath DC; van den Heuvel OA; van der Werf YD; Schöls C; Veltman DJ; Pouwels PJW
Psychoneuroendocrinology; 2017 Mar; 77():211-217. PubMed ID: 28104554
[TBL] [Abstract][Full Text] [Related]
14. Investigation of anterior cingulate cortex gamma-aminobutyric acid and glutamate-glutamine levels in obsessive-compulsive disorder using magnetic resonance spectroscopy.
Li Y; Zhang CC; Kathrin Weidacker ; Zhang Y; He N; Jin H; Chen W; Voon V; Edden RAE; Yan F
BMC Psychiatry; 2019 May; 19(1):164. PubMed ID: 31146727
[TBL] [Abstract][Full Text] [Related]
15. Pregenual Anterior Cingulate Dysfunction Associated with Depression in OCD: An Integrated Multimodal fMRI/
Tadayonnejad R; Deshpande R; Ajilore O; Moody T; Morfini F; Ly R; O'Neill J; Feusner JD
Neuropsychopharmacology; 2018 Apr; 43(5):1146-1155. PubMed ID: 29052616
[TBL] [Abstract][Full Text] [Related]
16. Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls.
Rosenberg DR; Mirza Y; Russell A; Tang J; Smith JM; Banerjee SP; Bhandari R; Rose M; Ivey J; Boyd C; Moore GJ
J Am Acad Child Adolesc Psychiatry; 2004 Sep; 43(9):1146-53. PubMed ID: 15322418
[TBL] [Abstract][Full Text] [Related]
17. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study.
Auer DP; Pütz B; Kraft E; Lipinski B; Schill J; Holsboer F
Biol Psychiatry; 2000 Feb; 47(4):305-13. PubMed ID: 10686265
[TBL] [Abstract][Full Text] [Related]
18. Proton magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for reduced neuronal integrity in the anterior cingulate.
Tükel R; Aydın K; Ertekin E; Özyıldırım SŞ; Taravari V
Psychiatry Res; 2014 Dec; 224(3):275-80. PubMed ID: 25241042
[TBL] [Abstract][Full Text] [Related]
19. Glutamatergic abnormalities in the pregenual anterior cingulate cortex in obsessive-compulsive disorder using magnetic resonance spectroscopy: A controlled study.
Kosová E; Pajuelo D; Greguš D; Brunovský M; Stopková P; Fajnerová I; Horáček J
Psychiatry Res Neuroimaging; 2023 Oct; 335():111721. PubMed ID: 37832259
[TBL] [Abstract][Full Text] [Related]
20. Relevance of orbitofrontal neurochemistry for the outcome of cognitive-behavioural therapy in patients with obsessive-compulsive disorder.
Zurowski B; Kordon A; Weber-Fahr W; Voderholzer U; Kuelz AK; Freyer T; Wahl K; Büchel C; Hohagen F
Eur Arch Psychiatry Clin Neurosci; 2012 Oct; 262(7):617-24. PubMed ID: 22427151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
